IL156144A0 - Novel therapeutic use of a thienylcyclohexylamine derivative - Google Patents

Novel therapeutic use of a thienylcyclohexylamine derivative

Info

Publication number
IL156144A0
IL156144A0 IL15614401A IL15614401A IL156144A0 IL 156144 A0 IL156144 A0 IL 156144A0 IL 15614401 A IL15614401 A IL 15614401A IL 15614401 A IL15614401 A IL 15614401A IL 156144 A0 IL156144 A0 IL 156144A0
Authority
IL
Israel
Prior art keywords
therapeutic use
novel therapeutic
thienylcyclohexylamine
derivative
thienylcyclohexylamine derivative
Prior art date
Application number
IL15614401A
Other languages
English (en)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of IL156144A0 publication Critical patent/IL156144A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15614401A 2000-12-20 2001-12-19 Novel therapeutic use of a thienylcyclohexylamine derivative IL156144A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0016631A FR2818147B1 (fr) 2000-12-20 2000-12-20 Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
PCT/FR2001/004050 WO2002049647A2 (fr) 2000-12-20 2001-12-19 Nouvelle application therapeutique d'un derive de la thienylcyclohexylamine

Publications (1)

Publication Number Publication Date
IL156144A0 true IL156144A0 (en) 2003-12-23

Family

ID=8857906

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15614401A IL156144A0 (en) 2000-12-20 2001-12-19 Novel therapeutic use of a thienylcyclohexylamine derivative

Country Status (20)

Country Link
US (2) US20050032840A1 (de)
EP (1) EP1359914B1 (de)
JP (1) JP2004525096A (de)
KR (1) KR20030070589A (de)
CN (1) CN1525860A (de)
AT (1) ATE337783T1 (de)
AU (1) AU2002225097A1 (de)
BR (1) BR0116373A (de)
CA (1) CA2432500A1 (de)
CZ (1) CZ20031727A3 (de)
DE (1) DE60122781D1 (de)
FR (1) FR2818147B1 (de)
HU (1) HUP0600063A2 (de)
IL (1) IL156144A0 (de)
MX (1) MXPA03005586A (de)
NO (1) NO20032799L (de)
PL (1) PL365913A1 (de)
RU (1) RU2003122231A (de)
WO (1) WO2002049647A2 (de)
ZA (1) ZA200305538B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858934B1 (fr) * 2003-08-22 2006-12-29 Helene Hirbec Composition pharmaceutique et son application dans le domaine de la neurologie en tant qu'agent modulateur du systeme glutamatergique
CN101163481A (zh) * 2005-03-04 2008-04-16 纽罗赛斯特克公司 改进的加环利定制剂
FR2946535B1 (fr) 2009-06-10 2011-09-09 Neureva Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639225B1 (fr) * 1988-11-21 1993-05-21 Centre Nat Rech Scient Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5972952A (en) * 1995-12-11 1999-10-26 Le Centre National De La Recherche Scientifique Neuroprotective pharmaceutical composition containing stereoisomers of arylcyclohexylamines
US6784194B2 (en) * 1996-12-06 2004-08-31 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Therapeutic use of a thienylcyclohexylamine derivative

Also Published As

Publication number Publication date
ZA200305538B (en) 2004-09-21
ATE337783T1 (de) 2006-09-15
NO20032799L (no) 2003-08-06
NO20032799D0 (no) 2003-06-19
MXPA03005586A (es) 2003-10-06
FR2818147B1 (fr) 2005-06-10
US20090023780A1 (en) 2009-01-22
CZ20031727A3 (cs) 2004-01-14
US20050032840A1 (en) 2005-02-10
RU2003122231A (ru) 2005-01-10
EP1359914B1 (de) 2006-08-30
AU2002225097A1 (en) 2002-07-01
CA2432500A1 (fr) 2002-06-27
EP1359914A2 (de) 2003-11-12
DE60122781D1 (de) 2006-10-12
PL365913A1 (en) 2005-01-10
FR2818147A1 (fr) 2002-06-21
JP2004525096A (ja) 2004-08-19
BR0116373A (pt) 2004-07-06
HUP0600063A2 (en) 2006-11-28
WO2002049647A3 (fr) 2003-09-04
KR20030070589A (ko) 2003-08-30
WO2002049647A2 (fr) 2002-06-27
CN1525860A (zh) 2004-09-01

Similar Documents

Publication Publication Date Title
IL136839A0 (en) Pharmaceutical compositions comprising cannabidiol derivatives
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
AU4513093A (en) Looped, hairpin ribozyme
WO2003030927A3 (fr) Utilisation de peptides analogues de la thymuline (pat) pour la fabrication de medicaments contre la douleur
EP1259240B8 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
AU2002213698A1 (en) Needleless syringe for the subcutaneous delivery of therapeutic agents
MXPA05003253A (es) Nuevos derivados de pirimidinamida y el uso de los mismos.
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
WO2002039997A3 (en) Ace-2 modulating compounds and use thereof
EP0657167A3 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingt Störungen, pharmaceutische Zusammensetzungen die Oenothein B enthalten und ein Verfahren zu ihrer Herstellung von Epilobium Parniflorum.
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
PL365913A1 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
BG106151A (en) Pharmaceutical complex
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
IL164921A0 (en) Synergistic interaction of abacavir and alovudine
HUP0300313A3 (en) Compound, pharmaceutical composition containing it and its use for the treatment of pain
GC0000336A (en) Pharmaceutical formulation comprising amoxycillin and clavulanate for the treatment of drug resistant s.pneumoniae